A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertension

Journal of Neurology

Volumn 246, Issue 11, 1999, Pages 1086-1089

  Quattrone, Aldo ^a,b   Gambardella, Antonio ^a,b   Carbone, Anna Maria ^c   Oliveri, R Luciano ^a,b   Lavano, Angelo ^c   De Marco, Elvira V ^b   Civitelli, Donatella ^b   Bono, Francesco ^a   Zappia, Mario ^a   Pardatscher, Kurt ^c   DiMinno, Giovanni ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b CNR   (Italy)

^c NONE

Author keywords

Cerebral venous thrombosis; Coagulation; Intracranial pressure; Obesity; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; D DIMER; HOMOCYSTEINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN VEIN; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MAGNETIC RESONANCE ANGIOGRAPHY; OBESITY; PRIORITY JOURNAL; THROMBOPHILIA; VEIN THROMBOSIS;

ADULT; CEREBRAL VEINS; FACTOR V; FEMALE; FIBRINOLYSIS; HUMANS; INTRACRANIAL HYPERTENSION; MUTATION; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; VENOUS THROMBOSIS;

EID: 0032754984     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050517     Document Type: Article

References (30)

1. 1. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF (1997) The mutation Ala677Val in the metylene tetrahydrofolate reductase gene: a risk factor for arterial and venous thrombosis. Thromb Haemost 77: 818-821
2. 2. Backhouse O, Metcalfe T, Goulding P, McEvoy M, Menage M (1998) Factor V Leiden mutation in association with idiopathic intracranial hypertension. Br J Ophthalmol 82:844
3. 3. Bertina RM, Rosendaal FR (1998) Venous thromboembolism - the interaction of genes and enviroment. N Engl J Med 338:1840-1841
4. 4. Bouchard C (ed) (1994) Genetics of obesity. CRC, Boca Raton
5. 5. Confavreux C, Brunet P, Petiot P, Berruyer M, Trillet M, Aimard G (1994) Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension. J Neurol Neurosurg Psychiatry 57:655-657
6. 6. Corbett JJ, Mehta MP (1983) Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 33:1386-1388
7. 7. Daif A, Awada A, al-Rajeh S, et al (1995) Cerebral venous thrombosis. A study of 40 cases from Saudi Arabia. Stroke 26:1193-1195
8. 8. Dandy WE (1937) Intracranial pressure without brain tumor. Ann Surg 106: 492-513
9. 9. De Franchis R, Mancini FP, D'Angelo A, et al (1996) Elevated total plasma homocysteine and 677 mutation of the 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59:262-264
10. 10. Deschiens MA, Conard J, Horellu MH, et al (1996) Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724-1730
11. 11. Di Minno G, Davi G, Margaglione M, et al (1993) Abnormally high thromboxane byosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest 92:1400-1406
12. 12. Gharavi AE, Harris EN, Asherson RA, Hughes GRV (1987) Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 46:1-6
13. 13. Johnston IH, Hawke SHB, Halmalagy GM, Teo C (1991) Pseudotumor cerebri: syndromes of intracranial hypertension without ventriculomegaly. Arch Neurol 48:740-747
14. 14. Juhan-Vague I, Vague PH, Alessi MC, et al (1987) Relationship between plasma insulin, triglyceride, body mass index and plasminogen activator inhibitor-1. Diabetes Metab Rev 13:370-373
15. 15. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198-202
16. 16. King JO, Mitchell PJ, Thomson KR, Tress BM (1995) Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 45:2224-2228
17. 17. Kuehnen J, Schwartz A, Neff W, Hennerici M (1998) Cranial nerve syndrome in thrombosis of the transverse/sigmoid sinuses. Brain 121:381-388
18. 18. Macko RF, Kittner SJ, Epstein A, et al (1999) Elevated tissue plasminogen activator antigen and stroke risk. Stroke 30:7-11
19. 19. Margaglione M, D'Andrea G, Cappucci G, et al (1996) Detection of the factor V Leiden using SSEP. Thromb Haemost 76:814-815
20. 20. Margaglione M, Grandone E, Vecchione G, et al (1997) Plasminogen activator inhibitor-1 (PAI-1) in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiotensin converting enzyme (ACE) genes. Atheroscler Thromb Vasc Biol 17: 2082-2087
21. 21. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338:1793-1797
22. 22. McMurdo SK Jr, Brant-Zawadzki M, Bradley WG Jr, Chang GY, Berg GO (1986) Dural sinus thrombosis: study using intermediate field strength MR imaging. Radiology 161:83-86
23. 23. Perl J, Turski PA, Masaryk TJ (1996) MR angiography. Techniques and clinical applications. In: Scott W (ed) Magnetic resonance imaging of the brain and spine, 2nd edn. Lippincott-Raven, Philadelphia, pp 1547-1618
24. 24. Perrier A, Desmarais S, Miron M-J, et al (1999) Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 353:190-195
25. 25. Radhakrishnan K, Ahlskog E, Cross SA, Kurland LT, O'Fallon WM (1993) Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 50:78-80
26. 26. Sussman J, Leach M, Greaves M, Malia R, Davie-Jones GAB (1997) Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 62:229-233
27. 27. Viganò-D'Angelo S, Comp PC, Esmon CT, D'Angelo A (1986) Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and selected disease states. J Clin Invest 77:416-424
28. 28. Wall M, George D (1991) Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain 114:155-180
29. 29. Wiman B (1995) Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb Haemost 74:71-76
30. 30. Working Group on Hemostasis of the Sociètè Française de Biologie Clinique (1993) Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemost 70:781-786